Product
OBI-999
1 clinical trial
1 indication
Indication
Locally Advanced Solid TumorClinical trial
A Phase 1/2, Open-Label, Dose-Escalation and Cohort-Expansion Study Evaluating the Safety, Pharmacokinetics, and Therapeutic Activity of OBI-999 in Patients With Advanced Solid TumorsStatus: Terminated, Estimated PCD: 2023-10-27